TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
1-Year Return
35.44%
This Quarter Return
-0.92%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$312M
AUM Growth
+$42.9M
(+16%)
Cap. Flow
+$55.7M
Cap. Flow
% of AUM
17.86%
Top 10 Holdings %
Top 10 Hldgs %
58.82%
Holding
92
New
32
Increased
17
Reduced
11
Closed
30
Top Buys
| 1 |
Amgen
AMGN
|
$28.9M |
| 2 |
AbbVie
ABBV
|
$21.5M |
| 3 |
DexCom
DXCM
|
$20.1M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$19.3M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$15.6M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$25.5M |
| 2 |
Johnson & Johnson
JNJ
|
$21.1M |
| 3 |
Medtronic
MDT
|
$14.2M |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$9.82M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$8.66M |
Sector Composition
| 1 | Healthcare | 92.91% |
| 2 | Industrials | 0.23% |
| 3 | Financials | 0.16% |
| 4 | Technology | 0.14% |
| 5 | Energy | 0.11% |
